| Fabino Enterprises Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.29 | 0.15 | 0.05 | 0.06 | 0.70 |
| Long Term Debt-Equity Ratio | 0.29 | 0.15 | 0.05 | 0.06 | 0.70 |
| Current Ratio | 1.87 | 2.84 | 10.78 | 6.61 | 2.22 |
| Fixed Assets | 28.86 | 19.30 | 13.44 | 12.00 | 10.74 |
| Inventory | 14.26 | 4.83 | 2.32 | 3.85 | 8.05 |
| Debtors | 2.41 | 1.39 | 1.69 | 3.03 | 1.67 |
| Interest Cover Ratio | 3.00 | 4.50 | 2.00 | 8.00 | 5.00 |
| PBIDTM (%) | 2.55 | 1.81 | 1.49 | 2.62 | 2.29 |
| PBITM (%) | 2.16 | 1.32 | 0.60 | 1.90 | 1.63 |
| PBDTM (%) | 1.83 | 1.48 | 1.19 | 2.38 | 1.96 |
| CPM (%) | 1.11 | 1.32 | 1.19 | 1.90 | 1.63 |
| APATM (%) | 0.72 | 0.82 | 0.30 | 1.19 | 0.98 |
| ROCE (%) | 7.13 | 1.88 | 0.46 | 2.71 | 2.79 |
| RONW (%) | 3.08 | 1.21 | 0.24 | 1.85 | 3.05 |